8-K: Cardlytics Announces Reverse Stock Split Amid Nasdaq Bid Price Concerns

Cardlytics, Inc. has implemented a 1-for-10 reverse stock split and reduced authorized shares to address Nasdaq's minimum bid price requirement, with a compliance deadline of November 30, 2026.

Summary

• Cardlytics received a notification from Nasdaq on June 3, 2026, stating that its common stock bid price has closed below $1.00 for 30 consecutive business days.
• The company has 180 days, until November 30, 2026, to regain compliance with the minimum bid price requirement.
• To comply, the stock must close at $1.00 or higher for ten consecutive business days before the compliance date.
• Cardlytics has filed a Certificate of Amendment to its charter to effect a 1-for-10 reverse stock split, effective June 5, 2026.
• This reverse stock split will also reduce the total number of authorized shares from 100,000,000 to 10,000,000.
• The reverse stock split will adjust convertible notes, stock options, and restricted stock units proportionally.
• The company's common stock will begin trading on a split-adjusted basis on Nasdaq on June 8, 2026.
• As of June 1, 2026, there were 58,078,634 shares outstanding; post-split, approximately 5,807,863 shares will be outstanding.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing negatively due to the company's non-compliance with Nasdaq's minimum bid price, necessitating a reverse stock split which often signals underlying business challenges.

Positives

• The company is taking proactive steps to regain compliance with Nasdaq listing rules.
• The reverse stock split is a common mechanism to increase share price and potentially attract a broader investor base.
• The company has a defined compliance date (November 30, 2026) and a clear path to regain compliance.
• Stockholders authorized the reverse stock split and authorized share reduction at the annual meeting, indicating support for the measure.

Negatives

• The company's common stock bid price has fallen below the $1.00 minimum requirement for 30 consecutive business days.
• Failure to regain compliance by November 30, 2026, could lead to delisting from the Nasdaq Global Market.
• The reverse stock split will increase the per-share exercise price of outstanding stock options and decrease the number of shares issuable.
• Fractional shares resulting from the split will be cashed out, potentially impacting small shareholders.

Risks

• The primary risk is the failure to meet the minimum bid price requirement of $1.00 for ten consecutive business days by November 30, 2026, which could lead to delisting.
• There is a risk that even with the reverse stock split, the stock price may not sustain above $1.00.
• The company may not be eligible for an additional 180-day compliance period if it fails to meet other listing requirements.
• An appeal of a delisting determination to a Nasdaq hearings panel is not guaranteed to be successful.

Future Outlook

The company intends to actively monitor its stock's closing bid price and evaluate options to regain compliance with Nasdaq's minimum bid price rule, including the possibility of a reverse stock split. If compliance is not achieved by the Compliance Date, the company may be eligible for an additional 180-day period if it meets other listing requirements.

Management Comments

• The Company intends to actively monitor the closing bid price of its common stock between now and the Compliance Date and will evaluate available options to resolve the deficiency and regain compliance with the minimum bid price rule, including by effecting a reverse stock split.

Industry Context

StockSavvy.ai notes that a bid price below $1.00 is a common trigger for Nasdaq delisting procedures. Many companies facing similar situations resort to reverse stock splits to artificially inflate their share price and avoid delisting, though this does not address underlying business performance issues.

Corporate Governance

Stakeholder Impact

• Shareholders: The reverse stock split will reduce the number of shares held proportionally, potentially affecting liquidity and perception. Fractional shares will be cashed out.
• Option Holders: Exercise prices will increase, and the number of shares issuable will decrease proportionally.
• RSU Holders: The number of shares issuable upon vesting will decrease proportionally.
• Creditors: The reverse stock split and authorized share reduction do not directly impact creditors but may reflect on the company's financial stability.

Next Steps

• Monitor the closing bid price of common stock until November 30, 2026.
• Evaluate available options to resolve the bid price deficiency.
• Effect a reverse stock split to regain compliance.
• If necessary, apply for an additional 180-day compliance period.
• Prepare for potential appeal of delisting determination if compliance is not achieved.

Key Dates

Recommendation

The reverse stock split is a procedural move to maintain Nasdaq listing and does not inherently improve the company's fundamental business prospects. While it avoids immediate delisting, the underlying reasons for the low stock price remain unaddressed. Investors should hold and await further operational improvements or strategic developments before considering a buy or sell decision.

Keywords

Cardlytics, 8-K, Nasdaq, Reverse Stock Split, Delisting, Compliance, Stock Price, SEC Filing